18575 JAMBOREE ROAD, IRVINE, CA
Reports First Quarter 2026 Financial Results
Annual Report to Security Holders
OnKure Therapeutics Enters $150M Securities Purchase Agreement
Reports Fourth Quarter and Full Year 2025 Financial Results
News, Underwriting Agreement
Financial Results, Press Release
Investor Presentation
Q1
FY 2025
Q3
Q2
FY 2024
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(3)
Definitive Proxy Statement
Additional Proxy Materials
Amended Schedule 13G - Ownership Report
Schedule 13D - Ownership Report
Initial Statement of Beneficial Ownership
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Post-Effective Amendment to Registration Statement